Cord Blood America, Inc. (CBAI.OB) Ranks 20th Largest Bio Company in Los Angeles
The Los Angeles Business Journal announced today that Cord Blood America, Inc. (CBAI.OB) has been ranked as the 20th largest biotech/biomed company in Los Angeles. Cord Blood went public in 2003 and is the second youngest public company to be included on the list, with annual revenues of $6 million and 15 employees. Cord Blood focuses on educating and assisting families in the benefits of storing life saving stem cells found in umbilical cords. Umbilical cord stem cells have successfully treated more than 70 medical conditions including leukemia, Hodgkin’s Disease, and anemia. Cord Blood provides 24/7 customer support with a…